Evaluation of Nilotinib In Patients With Advanced Gastrointestinal Stromal Tumor (GIST)

Update Il y a 4 ans
Reference: NCT01110668

Woman and Man

  • | Country :
  • Turkey
  • | organs :
  • -
  • | Specialty :
  • -

Extract

This study will assess time-to-disease progression in patients with advanced gastrointestinal stromal tumor (GIST) previously treated with imatinib ≥600 mg.


Inclusion criteria

  • Gastrointestinal stromal tumor

Links